Related Experiment Video
Updated: Sep 9, 2025

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
DDR kinase inhibition causes hypersensitivity to Taxol through caspase-3 activation
Megan Zaiger1, Junko Maeda1, Mami Murakami2
1Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA.
Abstract:
Taxol is an antitumor agent that arrests cells in the late G2 and M phases of the cell cycle. Our previous research demonstrated that PARP inhibition enhances Taxol-induced cell death via oxidative stress and free radical production. In this study, we hypothesized that the inhibiting DNA damage response (DDR) kinases would further increase Taxol cytotoxicity by impairing the repair of Taxol-induced DNA damage. We found that inhibition of PI3K-like DDR kinases enhanced Taxol-induced apoptosis through caspase-3 activation. We used Chinese hamster V79 cells and their ATM, ATR, and Ku80-deficient mutants which exhibited hypersensitivity to Taxol. Pharmacological inhibitors, KU55933 (ATM), NU7441 (DNA-PK), and VE821 (ATR), also sensitized V79, CHO, and U2OS human cancer cells to Taxol. This sensitization was associated with increased apoptosis, confirmed by sub-G1 analysis and caspase-3/7 activity assays. Interestingly, MCF7 cells, which lack caspase-3, did not show enhanced sensitivity to Taxol under DDR inhibition. In contrast, MCF7-C3 cells, with restored caspase-3 expression, exhibited significant apoptosis and sensitization, confirming a caspase-3 dependent mechanism. These findings suggest that ATM, ATR, and DNA-PK not only facilitate DNA repair but also suppress Taxol-induced apoptosis via caspase-3. Their inhibition may represent a promising strategy to boost their efficacy of Taxol and potentially enhance responses to radiation therapy through combined targeting of mitotic stress and DDR pathways.
Insights
Inhibiting DNA damage response (DDR) kinases enhances Taxol chemotherapy by increasing cancer cell death. This approach, targeting ATM, ATR, and DNA-PK, boosts Taxol
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Taxol (paclitaxel) is a key chemotherapy agent targeting cell cycle arrest.
- PARP inhibition previously showed synergy with Taxol via oxidative stress.
- DNA damage response (DDR) pathways are crucial for repairing chemotherapy-induced DNA damage.
Purpose of the Study:
- To investigate if inhibiting DDR kinases enhances Taxol-induced cancer cell death.
- To determine the role of specific DDR kinases (ATM, ATR, DNA-PK) in Taxol resistance.
- To elucidate the mechanism of DDR inhibition-mediated sensitization to Taxol.
Main Methods:
- Utilized Chinese hamster V79 cells and their ATM, ATR, and Ku80-deficient mutants.
- Employed pharmacological inhibitors: KU55933 (ATM), NU7441 (DNA-PK), and VE821 (ATR).
- Tested sensitization in V79, CHO, and U2OS human cancer cells; assessed apoptosis via sub-G1 analysis and caspase-3/7 assays. Investigated caspase-3 dependence using MCF7 and MCF7-C3 cells.
Main Results:
- Inhibition of PI3K-like DDR kinases significantly enhanced Taxol-induced apoptosis.
- ATM, ATR, and DNA-PK deficient cells showed hypersensitivity to Taxol.
- Sensitization was dependent on caspase-3 activation, as shown by experiments with caspase-3 deficient/proficient cells.
Conclusions:
- ATM, ATR, and DNA-PK kinases play a role in both DNA repair and suppressing Taxol-induced apoptosis.
- Inhibiting these DDR kinases represents a potential strategy to improve Taxol efficacy.
- Combined targeting of mitotic stress and DDR pathways could enhance Taxol and radiation therapy responses.
More Related Videos
06:02Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
MAPK Signaling Cascades
The Extrinsic Apoptotic Pathway
PI3K/mTOR/AKT Signaling Pathway
The Intrinsic Apoptotic Pathway